000 01026 a2200289 4500
005 20250515051550.0
264 0 _c20070125
008 200701s 0 0 eng d
022 _a1472-6483
024 7 _a10.1016/s1472-6483(10)61040-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEdwards, R G
245 0 0 _aOpen conflict on the handling of the Merck drug Vioxx by editorial giants.
_h[electronic resource]
260 _bReproductive biomedicine online
_cDec 2006
300 _a905 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCyclooxygenase 2 Inhibitors
_xadverse effects
650 0 4 _aDrug Industry
650 0 4 _aEditorial Policies
650 0 4 _aHumans
650 0 4 _aLactones
_xadverse effects
650 0 4 _aPublishing
650 0 4 _aScientific Misconduct
650 0 4 _aSulfones
_xadverse effects
773 0 _tReproductive biomedicine online
_gvol. 13
_gno. 6
_gp. 905
856 4 0 _uhttps://doi.org/10.1016/s1472-6483(10)61040-1
_zAvailable from publisher's website
999 _c16737390
_d16737390